Related Experiment Videos
Substance misuse in patients with schizophrenia: a primary care guide
1Orygen Research Centre, Cognitive Neuropsychiatry Research and Academic Unit, University of Melbourne, VIC. dan.lubman@mh.org.au
The Medical Journal of Australia
|May 2, 2003
Abstract:
Smoking presents a substantial health and economic burden to people with schizophrenia. Comorbid use of other substances is common, under-recognised, and associated with a number of serious adverse consequences, such as psychotic relapse and poorer social outcomes. All patients with schizophrenia need to be screened for substance misuse. Effective interventions involve integrated, modified pharmacological and psychosocial strategies.